These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7488333)

  • 21. Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Anti-Oxidant Therapy in Chronic Renal Insufficiency (ATIC) Study.
    Nanayakkara PW; van Guldener C; ter Wee PM; Scheffer PG; van Ittersum FJ; Twisk JW; Teerlink T; van Dorp W; Stehouwer CD
    Arch Intern Med; 2007 Jun; 167(12):1262-70. PubMed ID: 17592099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal metabolism of homocysteine in vivo.
    Brosnan JT; Hall B; Selhub J; Nadeau MR; Bostom AG
    Biochem Soc Trans; 1995 Aug; 23(3):470S. PubMed ID: 8566366
    [No Abstract]   [Full Text] [Related]  

  • 23. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
    De Vriese AS; Verbeke F; Schrijvers BF; Lameire NH
    Kidney Int; 2002 Apr; 61(4):1199-209. PubMed ID: 11918726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uptake and release of amino acids by normal and remnant kidneys: studies in the isolated perfused rat kidney.
    Perez G; Epstein M; Reitberg B; Horton C; Loutzenhiser R
    Am J Clin Nutr; 1980 Jul; 33(7):1373-7. PubMed ID: 7395765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasma homocysteine, vitamin B6, vitamin B12 and folic acid in end-stage renal disease during low-dose supplementation with folic acid.
    Hong SY; Yang DH; Chang SK
    Am J Nephrol; 1998; 18(5):367-72. PubMed ID: 9730558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.
    Anwar W; Guéant JL; Abdelmouttaleb I; Adjalla C; Gérard P; Lemoel G; Erraess N; Moutabarrek A; Namour F
    Clin Chem Lab Med; 2001 Aug; 39(8):747-52. PubMed ID: 11592445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications.
    Perna AF; Ingrosso D; Castaldo P; De Santo NG; Galletti P; Zappia V
    Miner Electrolyte Metab; 1999; 25(1-2):95-9. PubMed ID: 10207268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The plasma levels of homocysteine are elevated in moderate renal insufficiency but do not predict the rate of progression.
    Samuelsson O; Lee DM; Attman PO; Knight-Gibson C; Mullen JK; Larsson R; Mulec H; Weiss L; Alaupovic P
    Nephron; 1999; 82(4):306-11. PubMed ID: 10450032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carotid artery stiffness in patients with end-stage renal disease: no effect of long-term homocysteine-lowering therapy.
    van Guldener C; Lambert J; ter Wee PM; Donker AJ; Stehouwer CD
    Clin Nephrol; 2000 Jan; 53(1):33-41. PubMed ID: 10661480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Frequency of hyperhomocysteinemia in hemodialysis patients with folic acid supplementation].
    Kárpáti I; Balla J; Szóke G; Bereczky Z; Páll D; Ben T; Toma K; Katona E; Mohácsi A; Paragh G; Varga Z; Kakuk G; Muszbek L
    Orv Hetil; 2002 Jul; 143(27):1635-40. PubMed ID: 12180000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homocysteinemia correlates with plasma thiol redox status in patients with end-stage renal disease.
    Palleschi S; De Angelis S; Rossi B; Diana L; Papa V; Severini G; Splendiani G
    Nephron Clin Pract; 2008; 108(2):c106-12. PubMed ID: 18212512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated homocysteine levels in patients with end-stage renal disease.
    Nair AP; Nemirovsky D; Kim M; Geer EB; Farkouh ME; Winston J; Halperin JL; Robbins MJ
    Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma homocysteine in renal failure.
    Hultberg B; Andersson A; Sterner G
    Clin Nephrol; 1993 Oct; 40(4):230-5. PubMed ID: 8261681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dimethylglycine accumulates in uremia and predicts elevated plasma homocysteine concentrations.
    McGregor DO; Dellow WJ; Lever M; George PM; Robson RA; Chambers ST
    Kidney Int; 2001 Jun; 59(6):2267-72. PubMed ID: 11380830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The importance of homocysteinemia measurement in chronic renal failure].
    Cabarkapa V; Stosić Z; Zeravica R; Ilincić B
    Med Pregl; 2007; 60 Suppl 2():81-3. PubMed ID: 18928165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IMPLICATIONS OF URINE PO2 FOR RENAL MEDULLARY BLOOD FLOW.
    APERIA AC; LIEBOW AA
    Am J Physiol; 1964 Mar; 206():499-504. PubMed ID: 14160973
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperhomocysteinemia in chronic renal failure patients: relation to tissue factor and platelet aggregation.
    Cetin O; Bekpinar S; Unlucerci Y; Turkmen A; Bayram C; Ulutin T
    Clin Nephrol; 2006 Feb; 65(2):97-102. PubMed ID: 16509458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between global leukocyte DNA methylation, renal function, carotid intima-media thickness and plasma homocysteine in patients with stage 2-4 chronic kidney disease.
    Nanayakkara PW; Kiefte-de Jong JC; Stehouwer CD; van Ittersum FJ; Olthof MR; Kok RM; Blom HJ; van Guldener C; ter Wee PM; Smulders YM
    Nephrol Dial Transplant; 2008 Aug; 23(8):2586-92. PubMed ID: 18287179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine clearance and methylation flux rates in health and end-stage renal disease: association with S-adenosylhomocysteine.
    Stam F; van Guldener C; ter Wee PM; Kulik W; Smith DE; Jakobs C; Stehouwer CD; de Meer K
    Am J Physiol Renal Physiol; 2004 Aug; 287(2):F215-23. PubMed ID: 15271686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of hyperhomocysteinemia with plasma sulfate and urine sulfate excretion in patients with progressive renal disease.
    Nakanishi T; Otaki Y; Hasuike Y; Nanami M; Itahana R; Miyagawa K; Nishikage H; Izumi M; Takamitsu Y
    Am J Kidney Dis; 2002 Nov; 40(5):909-15. PubMed ID: 12407634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.